Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis

BACKGROUND: The European Academy of Allergy and Clinical Immunology recommended the Combined Symptom and Medication Score (CSMS) as primary endpoint in clinical trials on allergen‐specific immunotherapy (AIT) in allergic rhinoconjunctivitis. Here, the correlation between the CSMS and the validated s...

Descripción completa

Detalles Bibliográficos
Autores principales: Palathumpattu, Binoy, Pieper‐Fürst, Ursula, Acikel, Cengizhan, Sahin, Hacer, Allekotte, Silke, Singh, Jaswinder, Hess, Mark, Sager, Angelika, Müller, Thomas, Mösges, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533220/
https://www.ncbi.nlm.nih.gov/pubmed/36225263
http://dx.doi.org/10.1002/clt2.12191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533220/
https://www.ncbi.nlm.nih.gov/pubmed/36225263
http://dx.doi.org/10.1002/clt2.12191

Ejemplares similares